COMMUNIQUÉS West-GlobeNewswire

MDxHealth Launches Capital Increase and Secures Debt Financing from Kreos Capital
26/09/2019
Press release Regulated information – Inside information 26 September 2019, 2:00 p.m. CEST IRVINE, CA, and HERSTAL, BELGIUM – 26 September 2019 – MDxHealth SA (Euronext Brussels: MDXH) (the " Company " or " MDxHealth [...]
MDxHealth Lance une Augmentation de Capital et Obtient un Financement par Emprunt auprès de Kreos Capital
26/09/2019
Communiqué de presse Information réglementée - Information privilégiée 26 septembre 2019, 14H00 HEC IRVINE, CA, et HERSTAL (BELGIQUE) – le 26 septembre 2019 – MDxHealth SA (Euronext Brussels: MDXH) (la " Société " ou " [...]
Apellis Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
CRESTWOOD, Ky. and WALTHAM, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Assertio Therapeutics to Present at the Annual Cantor Fitzgerald Global Healthcare Conference
26/09/2019
LAKE FOREST, Ill., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT) today announced that members of senior management will participate at the Annual Cantor Fitzgerald Global Healthcare [...]
LogicBio Therapeutics to Present at October Conferences
26/09/2019
CAMBRIDGE, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today [...]
Immutep Announces Expansion of Part A of TACTI-002 Phase II Clinical Trial due to Positive Interim Data
26/09/2019
Requisite clinical responses achieved in cohort 1 of Part A (1 st line NSCLC) of TACTI-002 Phase II clinical trial to allow for recruitment of cohort 2 Recruitment of cohort 2 of Part A of TACTI-002, additional 19 [...]
Medtronic Announces New Clinical Trial to Study Infuse Bone Graft in TLIF Spine Procedures
26/09/2019
Medtronic Continues to Invest in Scientific Evidence for Expansion of Indications and Greater Clinical Understanding of Infuse™ Bone Graft DUBLIN and CHICAGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) [...]
PetVivo Holdings, Inc. Featured in New Research Update
26/09/2019
MINNEAPOLIS, MN, Sept. 26, 2019 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV), an emerging biomedical device company, is very pleased to announce that Marble Arch Research Inc., a leading independent equity [...]
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
26/09/2019
SAN DIEGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (“Arcturus” or the “Company”), a leading RNA medicines company focused on the discovery, development and commercialization of mRNA therapeutics for [...]
RedHill Biopharma Provides H2/2019 R&D Update
26/09/2019
TEL-AVIV, Israel and RALEIGH, N.C., Sept. 26, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company [...]
Global Marketing and Strategy Leader Martha Pease Joins BioSig Board of Directors
26/09/2019
Fortune 500 business veteran brings unrivalled expertise in building brands and transformational tech innovation Westport, CT, Sept. 26, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ:BSGM), a medical device [...]
OpGen to Present on Guiding Precision Antibiotic Therapy with Rapid Genomics and Informatics at IDWeek 2019
26/09/2019
Acuitas® AMR Gene Panel and Acuitas Lighthouse® Software to be highlighted in a conference speaker session GAITHERSBURG, Md., Sept. 26, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc . (Nasdaq: OPGN) announced today that data from [...]
MacroGenics to Participate in Cantor Global Healthcare Conference
26/09/2019
ROCKVILLE, MD, Sept. 26, 2019 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Marinus Pharmaceuticals Announces Positive Top-Line Results With Ganaxolone in Phase 2 Refractory Status Epilepticus Trial
26/09/2019
All patients achieved the primary endpoint Target Phase 3 dose identified Preparing for End-of-Phase 2 meeting with FDA Oral platform presentation at Neurocritical Care Society meeting in October Conference call and [...]
Arbutus to Participate in Upcoming Investor Conferences
26/09/2019
WARMINSTER, Pa., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that the Company will be [...]
SI-BONE, Inc. Announces Publication of Five-Year Prospective Study Results on 103 Patients Treated with Triangular Titanium iFuse Implant System
26/09/2019
Long-term follow-up results show excellent durability of clinical responses and positive radiographic outcomes for SI joint fusion using triangular titanium implants SANTA CLARA, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE [...]
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on October 3, 2019
26/09/2019
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez, [...]
U.S. Government Exercises Option for Additonal Rapivab® for Strategic National Stockpile
26/09/2019
$14 million in non-dilutive capital added by year end RESEARCH TRIANGLE PARK, N.C., Sept. 26, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the U.S. Department of Health and [...]
Codexis to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
26/09/2019
REDWOOD CITY, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at the 2019 Cantor Fitzgerald Global Healthcare [...]

Pages